Abstract
Summary: Oxidative stress contributes to the pathogenesis of aging‐associated heart failure. Among various signaling pathways mediating oxidative stress, the NAD+‐dependent protein deacetylase SirT1 has been implicated in the protection of heart muscle. Expression of a locally acting insulin‐like growth factor‐1 (IGF‐1) propeptide (mIGF‐1) helps the heart to recover from infarct and enhances SirT1 expression in cardiomyocytes (CM) in vitro, exerting protection from hypertrophic and oxidative stresses. To study the role of mIGF‐1/SirT1 signaling in vivo, we generated cardiac‐specific mIGF‐1 transgenic mice in which SirT1 was depleted from adult CM in a tamoxifen‐inducible and conditional fashion. Analysis of these mice confirmed that mIGF‐1‐induced SirT1 activity is necessary to protect the heart from paraquat (PQ)‐induced oxidative stress and lethality. In cultured CM, mIGF‐1 increases SirT1 expression through a c‐Jun NH(2)‐terminal protein kinase 1 (JNK1)‐dependent signaling mechanism. Thus, mIGF‐1 protects the heart from oxidative stress via SirT1/JNK1 activity, suggesting new avenues for cardiac therapy during aging and heart failure.

This publication has 45 references indexed in Scilit: